ABOUT US
Pioneering Virtual Reality Therapy for Chronic Pain Relief
OUR MISSION
Help people reclaim their lives from chronic pain—using the power of the
mind,
science
and
technology.
Millions live with chronic pain that persists long after the original injury heals. Traditional treatments often focus only on the body—medications, injections and surgeries that come with risks or limited success.
Now, modern research has shown what many have long felt:
Chronic pain also lives in the brain.
We created VRNT to fill the gap—a therapy that works with the brain, not against it. VRNT uses immersive, guided experiences in virtual reality to help patients retrain their pain pathways, reduce pain sensitivity and regain function—all from home, in minutes a day.
What Drives Us
We work alongside physicians, therapists and researchers to continuously improve VRNT and bring the future of pain therapy into the present.
Our Team
CognifiSense was founded by Tassilo Baeuerle, a serial entrepreneur in tech and medical innovation, and Harald Stock, PhD, a visionary in pain treatment and pharmaceutical leadership. Together, they set out to create a therapy that combined cutting-edge virtual reality with evidence-based neuropsychology.
Now led by CEO Amanda Way, CognifiSense is scaling VRNT to patients and providers across the country, making this new era of pain care accessible to the people who need it most.
Amanda Way
M.S. Clinical Informatics Man. ​
Experienced biotech & healthcare investor and board member across Emerson Collective and JAZZ Venture Partners. Previous founder (acquired), optgenetics researcher and EMT. Global Program Director at LSI.
Tassilo Baeuerle
M. Engineering, MBA
Neurotech disruptor with multiple healthcare XR patents. 15+ years as execution-focused CEO, including 6 turnarounds. Led Tier 1 VC-funded startup to successful exit.
Dr. Harald Casebourne-Stock
Ph.D. Inorganic Chemistry
20+ years of step-change value creation through strategic corporate development. Three times mid-cap healthcare CEO, incl. Grünenthal (top-3 pain pharma). Serial biotech co-founder & NED; 6 IPOs, 4 M&As, $1b+ financings/transactions
CognifiSense in the News
From groundbreaking clinical results to recognition by the FDA, our mission to transform pain management is resonating across the healthcare and tech landscapes. Explore recent press coverage, expert interviews and media features highlighting how VRNT is changing lives.
Cognifisense welcomes Amanda Way as CEO
September 2024CognifiSense publishes paper on successful pilot of its patented VR tech to measure pain
May 2020Venture Capital firm SocialStarts invests in CognifiSense
April 2020Venture Capital firm Joyance Partners invests in CognifiSense
April 2020CognifiSense gets NIH / HEAL grant
NIH funds $945mil in research to tackle the national opioid crisis through NIH Heal Initiative
CognifiSense's VRNT winner of FDA Innovation Challenge
FDA Innovation Challenge: Devices to prevent and treat opioid use disorder
Can virtual reality relieve chronic pain?
Doctors and researchers think that VR can alleviate chronic pain, reducing patients’ need for opioid painkillers.
Physical therapy professor uses VR to provide pain management
Dr. Maureen Simmonds hopes VR will allow patients to reduce dependency on medication.